News
Search EMA's news announcements
Om det språk som visas
Den här sidan är inte tillgänglig på ditt valda språk via webbplatsens maskinöversättningstjänst.
Sidan visas därför i den engelska originalversionen.
On 29 September 2026, we updated the search paths shown in your browser's address bar to make them easier to read and understand. As a result, links to search results that you previously bookmarked may no longer work. We advise you to carry out your search again.
Acoziborole Winthrop simplifies treatment of first- and second-stage disease caused by T. brucei gambiense

12 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications
Ojemda addresses unmet need for patients aged 6 months and older with paediatric brain tumour with BRAF alterations

Candidates have until 19 March to apply for the role
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting

PRAC concludes safety review of levamisole, a medicine used to treat parasitic worm infections
Leukoencephalopathy confirmed as a serious side effect of levamisole
Rezurock addresses unmet need when other treatments are unsuccessful or unsuitable
Kygevvi improves motor function of patients with disease onset at or before 12 years of age
Review prompted by questions regarding data integrity of main study